Percutaneous closure of Ostium secundum atrial septal Defect using amplatzer Occlusion Device

##plugins.themes.academic_pro.article.sidebar##

Published Aug 21, 2013
Download
pdf
Vol. 91 No. 7 (2013): Issue Jul 2013

##plugins.themes.academic_pro.article.main##

Dorra Abid
Noomen Rekik
Souad Mallek
Leila Abid
Malek Akrout
Mohamed Smaoui
Mohamed Abdennadher
Kamel Kolsi
Imed Frikha
Samir Kammoun

Abstract

aim: To report our clinical experience with transcatheter closure of ostium secundum atrial septal defects (OS ASDs) using Amplatzer septal occluder.
methods: It’s a retrospective study conducted between October 2005 and April 2010 and involving 34 patients. The procedures were conducted in the hemodynamic laboratory under general anesthesia with transthoracic (TTE) and transoesophageal echocardiographic (TEE) monitoring. Clinical and echocardiography assessments of the patients were conducted within 24 hours post procedure and several months after the procedure.
results: From the 34 patients, 28 (82%) were females. The middle age was 27.5 years. The mean ASD diameter was 19.4 mm by TTE; 18.1 mm [12-38] by TEE, and 23.4 by angiography. The average size of the implanted devices was 23.2 mm ranging from 10 to 34 mm.The final success rate of the procedure was 90.9% (30/33). One patient was excluded from transcatheter occlusion and three patients (8,6%) had complications including two prosthesis migrations and one large residual shunting. A total of 4 patients (11,7%) underwent surgery. No major complication (thromboembolic events, obstruction of intracardiac structures, cardiac perforation, device embolization and endocarditis) or death has occurred during follow-up and all devices were securely anchored without any persistent residual shunts.
Conclusion: Compared to previous data of the literature, percutaneous closure of OS ASDs using Amplatzer device appears safe and effective according to our experience of the cardiology department of Hedi Chaker Hospital.

Keywords:

Atrial Septal Defect, Amplatzer, Percutaneous closure.

##plugins.themes.academic_pro.article.details##

References

  1. Ward C. Secundum atrial septal defect: routine surgical treatment is not of proven benefit. Br Heart J 1994; 71: 219-23.
  2. Dickinson DF, Arnold R, Wilkinson JL. Congenital heart disease among 160,480 live-born children in Liverpool 1960 to 1969. Implications for surgical treatment. Br Heart J. 1981; 46: 55-62.
  3. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976; 235: 2506-9.
  4. Berger F, Ewert P, Björnstad PG, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer's septal occluder. Cardiol Young 1999; 9: 468-73.
  5. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new selfcentering Amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997; 42: 388-93.
  6. Cao QL, Radtke W, Berger F, Zhu W, Hijazi ZM. Transcatheter closure of multiple atrial septal defects. Initial results and value of two- and three-dimensional transoesophageal echocardiography. Eur Heart J. 2000; 21: 941-7.
  7. Sharafuddin MJA, Xiaoping G, Titus JL, Urness M, Cervera- Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects. Preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 1997; 95:2162-8.
  8. Rao PS, Langhough R, Beekman RH, Lloyd TR, Sideris B. Echocardiographic estimation of balloon stretched diameter of Secundum atrial septal defect for transcatheter occlusion. Am Heart J 1992; 124: 172-5.
  9. Patel A, Cao QL, Koenig PR, Hijazi ZM. Intracardiac echocardiography to guide closure of atrial septal defects in children less than 15 kilograms. Catheter Cardiovasc Interv. 2006; 68: 287-91.
  10. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39:1061-5.
  11. Carminati M, Chessa M, Butera G, et al. Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up. J Interv Cardiol 2001; 14:319-24.
  12. Butera G, Carminati M, Chessa M et al. CardioSEAL/ STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects. Am Heart J 2004; 148:507-10.
  13. Thanopoulos BD, Laskari CV, Tsaousis GC, Zarayelyan A, Vekiou A, Papadopoulos GS. Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 1988; 31:1110-6.
  14. Du ZD, Koenig P, Cao QL, Waight D, Heitschmidt M, Hijazi ZM. Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims. Am J Cardiol 2002; 90:865-69.
  15. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atria septal defect in children and adults: Results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002; 39:1836-44.
  16. Masura J, Gavora P, Formanek A, Hijazi Z. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer Septal Occluder: initial human experience. Cathet Cardiovasc Diag 1997; 42: 388-93.
  17. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single center study in 236 consecutive patients. Heart 2003; 89:199-204.
  18. Verma PK, Thingnam SK, Sharma A, Taneja JS, Varma JS, Grover A. Delayed embolisation of Amplatzer septal occluder device: an unknown entity. A case report. Angiology 2003; 54:115-8.
  19. Hijazi Z, Wang Z, Cao Q, Koenig P, Waight D, Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance: Feasibility and comparison with transesophageal echocardiography. Catheter Cardiovasc Interv 2001;52:194-99.
  20. Rao PS, Sideris EB, Hausdorf G et al. International experience with secundum atrial septal defect occlusion by the buttoned device. Am Heart J 1994; 128: 1022-35.
  21. Sievert H, Babic UU, Ensslen R et al. Occlusion of atrial septal defect with a new occlusive device. Z Kardiol 1996; 85: 97-103.
  22. Yew G, Wilson NJ. Transcatheter atrial septal defect closure with the Amplatzer septal occluder: five-year follow-up. Catheter Cardiovasc Interv 2005; 64:193-6.
  23. Zhong-Dong Du, Ziyad M. Hijazi, Charles S. Kleinman, Norman H. Silverman, Kinley Larntz. Comparison between Transcatheter and Surgical Closure of Secundum Atrial Septal Defect in Children and Adults Results of a Multicenter Nonrandomized Trial. J Am Coll Cardiol 2002; 39:1836-44
  24. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, for the Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002; 39:1836-44.
  25. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg. 1999; 118:674-8.
  26. Kim JJ, Hijazi ZM. Clinical outcomes and costs of Amplatzer transcatheter closure as compared with surgical closure of ostium Secundum atrial septal defects. Med Sci Monit. 2002; 8:787-91.
  27. Schoen SP, Boscheri A, Lange SA, et al. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale. Heart 2008; 94:844-7.